Your browser doesn't support javascript.
loading
PHC1 maintains pluripotency by organizing genome-wide chromatin interactions of the Nanog locus.
Chen, Li; Tong, Qiaoqiao; Chen, Xiaowen; Jiang, Penglei; Yu, Hua; Zhao, Qianbing; Sun, Lingang; Liu, Chao; Gu, Bin; Zheng, Yuping; Fei, Lijiang; Jiang, Xiao; Li, Wenjuan; Volpe, Giacomo; Abdul, Mazid Md; Guo, Guoji; Zhang, Jin; Qian, Pengxu; Sun, Qiming; Neculai, Dante; Esteban, Miguel A; Li, Chen; Wen, Feiqiu; Ji, Junfeng.
Afiliação
  • Chen L; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Tong Q; Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.
  • Chen X; Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine, Hangzhou, 310058, China.
  • Jiang P; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Yu H; Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.
  • Zhao Q; Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine, Hangzhou, 310058, China.
  • Sun L; Division of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, 518026, China.
  • Liu C; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Gu B; Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.
  • Zheng Y; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Fei L; Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.
  • Jiang X; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Li W; Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.
  • Volpe G; Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine, Hangzhou, 310058, China.
  • Abdul MM; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Guo G; Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.
  • Zhang J; Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine, Hangzhou, 310058, China.
  • Qian P; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Sun Q; Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.
  • Neculai D; Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine, Hangzhou, 310058, China.
  • Esteban MA; ZJU-UoE Joint Institute, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
  • Li C; Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, Canada.
  • Wen F; Department of Cell Biology, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
  • Ji J; Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Nat Commun ; 12(1): 2829, 2021 05 14.
Article em En | MEDLINE | ID: mdl-33990559
Polycomb group (PcG) proteins maintain cell identity by repressing gene expression during development. Surprisingly, emerging studies have recently reported that a number of PcG proteins directly activate gene expression during cell fate determination process. However, the mechanisms by which they direct gene activation in pluripotency remain poorly understood. Here, we show that Phc1, a subunit of canonical polycomb repressive complex 1 (cPRC1), can exert its function in pluripotency maintenance via a PRC1-independent activation of Nanog. Ablation of Phc1 reduces the expression of Nanog and overexpression of Nanog partially rescues impaired pluripotency caused by Phc1 depletion. We find that Phc1 interacts with Nanog and activates Nanog transcription by stabilizing the genome-wide chromatin interactions of the Nanog locus. This adds to the already known canonical function of PRC1 in pluripotency maintenance via a PRC1-dependent repression of differentiation genes. Overall, our study reveals a function of Phc1 to activate Nanog transcription through regulating chromatin architecture and proposes a paradigm for PcG proteins to maintain pluripotency.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatina / Células-Tronco Pluripotentes Induzidas / Complexo Repressor Polycomb 1 / Proteína Homeobox Nanog Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatina / Células-Tronco Pluripotentes Induzidas / Complexo Repressor Polycomb 1 / Proteína Homeobox Nanog Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article